List of works - Verena Schroeder

A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.

scientific article published on 15 September 2011

Acquired factor XIII deficiency: a therapeutic challenge.

scientific article published on 10 January 2013

Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder

scientific article published on 01 January 2006

Coagulation Factor XIII in Cerebral Venous Thrombosis

scientific article published on 22 July 2019

Coagulation factor XIII activation peptide and subunit levels in patients with acute ischaemic stroke: a pilot study

scientific article published on 01 July 2010

Coagulation factor XIII-A subunit and activation peptide levels in individuals with established symptomatic acute deep vein thrombosis

scientific article

Complement C3 is a novel plasma clot component with anti-fibrinolytic properties

scientific article published on 17 January 2012

Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation

scientific article published on 18 October 2012

Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations

scientific article published on 16 December 2013

Diabetes affects endothelial cell function and alters fibrin clot formation in a microvascular flow model: A pilot study

scientific article published on 01 January 2020

Effects of MASP-1 of the Complement System on Activation of Coagulation Factors and Plasma Clot Formation ⬇️

scientific article published on April 20, 2012

Factor XIII activation by thrombin depends on FXIIIVal34Leu genotype

scientific article published on 01 January 2003

Factor XIII deficiency: an update.

scientific article published on 08 August 2013

Factor XIII in severe sepsis and septic shock

scientific article published on 30 March 2006

Factor XIII: Structure and Function.

scientific article published on 28 March 2016

Factor XIII plasma levels in women with unexplained recurrent pregnancy loss

scientific article published on 01 April 2012

Free factor XIII activation peptide affects factor XIII function

scientific article published on 04 October 2014

Further evidence of heterogeneity of gene defects in Italian families with factor XIII deficiency.

scientific article published on 4 August 2011

Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3.

scientific article published on 17 May 2014

Identification of a novel nonsense mutation leading to congenital factor XIII deficiency

scientific article published on 27 March 2018

Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function.

scientific article

Identification of two novel missense mutations causing severe factor XIII deficiency.

scientific article published on 31 March 2015

Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography

scientific article published on 01 December 2001

MASP-1 Induced Clotting--The First Model of Prothrombin Activation by MASP-1.

scientific article published on 8 December 2015

MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model.

scientific article

MASP-1 of the complement system promotes clotting via prothrombin activation

scientific article published on 3 March 2015

Molecular characterization of five Italian families with inherited severe factor XIII deficiency.

scientific article published on 20 November 2007

Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation.

scientific article

New developments in the area of factor XIII.

scientific article published on February 2013

Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations.

scientific article published in September 2007

Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases.

scientific article published in July 2013

Plasma levels of mannan-binding lectin-associated serine proteases MASP-1 and MASP-2 are elevated in type 1 diabetes and correlate with glycaemic control

scientific article published on 01 May 2015

Prediction of Cerebral Venous Thrombosis with a new clinical score and D-dimer levels

scientific article published on 23 June 2020

Proinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with Type 2 diabetes

scientific article published on 01 September 2010

Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen Activation

scientific article published on 12 November 2018

Relation of depression to various markers of coagulation and fibrinolysis in patients with and without coronary artery disease

scientific article published on 01 December 2007

Role of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with acute pulmonary embolism

scientific article published on 01 March 2003

Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events

scientific article

TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays

scientific article published on 01 August 2006

TAFI and PAI-1 levels in human sepsis

scientific article published on 11 July 2005

The activation peptide of coagulation factor XIII is vital for its expression and stability.

scientific article

Thrombelastographic studies on factor XIII

scientific article published on 13 September 2010

Venous and intracoronary factor XIII A-subunit antigen and activity levels are not associated with extent of coronary artery disease

scientific article published on 01 April 2003

[Complement--a phylogenetically old system as a new player in the development of atherosclerosis]

scientific article published on 06 March 2012

List of works by Verena Schroeder

A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.

Acquired factor XIII deficiency: a therapeutic challenge.

Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder

Coagulation Factor XIII in Cerebral Venous Thrombosis

Coagulation factor XIII activation peptide and subunit levels in patients with acute ischaemic stroke: a pilot study

Coagulation factor XIII-A subunit and activation peptide levels in individuals with established symptomatic acute deep vein thrombosis

Complement C3 is a novel plasma clot component with anti-fibrinolytic properties

Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation

Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations

Diabetes affects endothelial cell function and alters fibrin clot formation in a microvascular flow model: A pilot study

Effects of MASP-1 of the Complement System on Activation of Coagulation Factors and Plasma Clot Formation ⬇️

Factor XIII activation by thrombin depends on FXIIIVal34Leu genotype

Factor XIII deficiency: an update.

Factor XIII in severe sepsis and septic shock

Factor XIII: Structure and Function.

Factor XIII plasma levels in women with unexplained recurrent pregnancy loss

Free factor XIII activation peptide affects factor XIII function

Further evidence of heterogeneity of gene defects in Italian families with factor XIII deficiency.

Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3.

Identification of a novel nonsense mutation leading to congenital factor XIII deficiency

Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function.

Identification of two novel missense mutations causing severe factor XIII deficiency.

Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography

MASP-1 Induced Clotting--The First Model of Prothrombin Activation by MASP-1.

MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model.

MASP-1 of the complement system promotes clotting via prothrombin activation

Molecular characterization of five Italian families with inherited severe factor XIII deficiency.

Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation.

New developments in the area of factor XIII.

Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations.

Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases.

Plasma levels of mannan-binding lectin-associated serine proteases MASP-1 and MASP-2 are elevated in type 1 diabetes and correlate with glycaemic control

Prediction of Cerebral Venous Thrombosis with a new clinical score and D-dimer levels

Proinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with Type 2 diabetes

Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen Activation

Relation of depression to various markers of coagulation and fibrinolysis in patients with and without coronary artery disease

Role of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with acute pulmonary embolism

Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events

TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays

TAFI and PAI-1 levels in human sepsis

The activation peptide of coagulation factor XIII is vital for its expression and stability.

Thrombelastographic studies on factor XIII

Venous and intracoronary factor XIII A-subunit antigen and activity levels are not associated with extent of coronary artery disease

[Complement--a phylogenetically old system as a new player in the development of atherosclerosis]